T1	Condition 392 419	Neurodegenerative disorders
T2	Condition-Name 392 419	Neurodegenerative disorders
E1	Condition:T1 Name:T2
T3	Condition 373 380	disease
T4	Condition-Name 373 380	disease
E3	Condition:T3 Name:T4 Severity:T40
T5	Condition 447 464	Immunosuppression
T6	Condition-Name 447 464	Immunosuppression
E5	Condition:T5 Name:T6
T11	Eq-Operator 482 483	<
A1	Eq-Operator-Value T11 LT
T12	Eq-Value 483 488	3,000
T13	Eq-Comparison 482 497	<3,000 cells/ml
E10	Eq-Comparison:T13 Operator:T11 Value:T12 Unit:T45 Per:T46
T16	Eq-Comparison 211 216	Prior
E12	Eq-Comparison:T16 Temporal-Period:T17
T17	Eq-Temporal-Period 211 216	Prior
A3	Eq-Temporal-Period-Value T17 past
T18	Condition 135 138	SCI
E2	Condition:T18 Name:T19
T19	Condition-Name 135 138	SCI
T20	Modifier 109 134	non-penetrating traumatic
E4	Modifier:T20 Modifies:T19
T21	Condition 144 165	Asia Impairment Scale
E6	Condition:T21 Name:T22 Stage:E8
T22	Condition-Name 144 165	Asia Impairment Scale
T23	Eq-Comparison 166 185	grade of A, B, or C
E8	Eq-Comparison:T23 Unit:T24 Value:T25 Value2:T26 Value3:T27
T24	Eq-Unit 166 171	grade
T25	Eq-Value 175 176	A
T26	Eq-Value 178 179	B
T27	Eq-Value 184 185	C
T14	Condition 245 251	injury
E11	Condition:T14 Name:T15 Temporality:E12
T15	Condition-Name 245 251	injury
T28	Modifier 239 244	Brain
E13	Modifier:T28 Modifies:T15
T29	Condition 280 289	infection
E14	Condition:T29 Name:T30 Temporality:E15
T30	Condition-Name 280 289	infection
T31	Eq-Comparison 272 279	ongoing
E15	Eq-Comparison:T31 Temporal-Period:T32
T32	Eq-Temporal-Period 272 279	ongoing
A2	Eq-Temporal-Period-Value T32 present
T33	Eq-Comparison 262 268	Recent
E16	Eq-Comparison:T33 Temporal-Period:T34
T34	Eq-Temporal-Period 262 268	Recent
A4	Eq-Temporal-Period-Value T34 recent
T35	Or 269 271	or
E17	Or:T35 Arg:E16 Arg2:E15
T9	Modifier 363 372	endocrine
E9	Modifier:T9 Modifies:T4
T10	Modifier 352 359	hepatic
E18	Modifier:T10 Modifies:T4
T36	Modifier 345 350	renal
E19	Modifier:T36 Modifies:T4
T37	Modifier 339 343	lung
E20	Modifier:T37 Modifies:T4
T38	Modifier 323 337	cardiovascular
E21	Modifier:T38 Modifies:T4
T39	Or 360 362	or
E22	Or:T39 Arg:E18 Arg2:E9
T40	Severity 311 322	significant
A5	Severity-Value T40 severe
T41	Condition 430 436	Cancer
E23	Condition:T41 Name:T42
T42	Condition-Name 430 436	Cancer
T43	Observation 479 482	WBC
E24	Observation:T43 Name:T44 Eq-Comparison:E10
T44	Observation-Name 479 482	WBC
A6	Observation-Type-Value T44 lab
T45	Eq-Unit 489 494	cells
T46	Eq-Unit 495 497	ml
T47	Study 501 509	baseline
E25	Study:T47 
T48	Temporal-Connection 498 500	at
E26	Temporal-Connection:T48 Arg:E24 Arg2:E25
A7	Temporal-Connection-Type-Value E26 during
R1	Equivalent-To Arg1:E24 Arg2:E5	
T49	Condition 531 534	HIV
E27	Condition:T49 Name:T50 Polarity:T51
T50	Condition-Name 531 534	HIV
T51	Polarity 534 535	+
A8	Polarity-Value T51 positive
T52	Condition 563 573	dependency
E28	Condition:T52 Name:T53
T53	Condition-Name 563 573	dependency
T7	Modifier 546 554	Chemical
E7	Modifier:T7 Modifies:T53
T8	Modifier 558 562	ETOH
E29	Modifier:T8 Modifies:T53
T54	Or 555 557	or
E30	Or:T54 Arg:E7 Arg2:E29
T55	Procedure 608 611	MRI
E31	Procedure:T55 Name:T56
T56	Procedure-Name 608 611	MRI
T57	Contraindication 588 604	contraindication
E32	Contraindication:T57 Contraindicates:E31
T58	Condition 646 664	medical conditions
E33	Condition:T58 Severity:T60
T59	Modifier 638 645	chronic
E34	Modifier:T59 Modifies:E33
T60	Severity 629 634	acute
A9	Severity-Value T60 severe
T61	Or 635 637	or
E35	Or:T61 Arg:T60 Arg2:E34
T62	Study 746 751	study
E36	Study:T62 
T63	Risk 724 729	risks
E37	Risk:T63 Stability:T64
R2	Caused-By Arg1:E36 Arg2:E37	
T64	Stability 711 719	increase
A10	Stability-Value T64 change
T65	Assertion 707 710	may
E38	Assertion:T65 Asserted:T64
A11	Assertion-Type-Value E38 hypothetical
R3	Caused-By Arg1:T64 Arg2:E33	
T66	Drug 769 777	HB-adMSC
E39	Drug:T66 Name:T67
T67	Drug-Name 769 777	HB-adMSC
T68	Or 766 768	or
E40	Or:T68 Arg:E36 Arg2:E39
T69	Study 845 852	studies
E41	Study:T69 
T70	Other 815 820	other
E42	Other:T70 Is-Other:E41
T71	Encounter 886 902	follow-up visits
E43	Encounter:T71 
T72	Negation 858 871	Unwillingness
E44	Negation:T72 Negates:E43
T73	Assertion 858 871	Unwillingness
E45	Assertion:T73 Asserted:E44
A12	Assertion-Type-Value E45 hypothetical
